South Korea
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
69.11%
|
Dec. 31, 2023 | USD 4.56 | -1.90% |
|
South Korea |
|
2 |
64.68%
|
Dec. 31, 2023 | USD 6.08 | -11.28% |
|
South Korea |
|
3 |
55.94%
|
March 31, 2024 | USD 1.03 | 1.60% |
|
South Korea |
|
4 |
45.79%
|
Dec. 31, 2023 | USD 745.69 | 1.15% |
|
South Korea |
|
5 |
44.06%
|
Dec. 31, 2023 | USD 165.82 | 0.68% |
|
South Korea |
|
6 |
38.08%
|
Dec. 31, 2023 | USD 4.14 | -7.03% |
|
South Korea |
|
7 |
33.19%
|
Dec. 31, 2023 | USD 1.30 | -2.54% |
|
South Korea |
|
8 |
31.58%
|
Dec. 31, 2023 | USD 24.65 | -4.63% |
|
South Korea |
|
9 |
30.72%
|
Dec. 31, 2023 | USD 2.37 | -7.94% |
|
South Korea |
|
10 |
29.96%
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
11 |
29.64%
|
Dec. 31, 2023 | USD 23.32 | 1.79% |
|
South Korea |
|
12 |
29.17%
|
Dec. 31, 2023 | USD 50.87 | -3.50% |
|
South Korea |
|
13 |
29.01%
|
Dec. 31, 2023 | USD 10.03 | -2.53% |
|
South Korea |
|
14 |
26.55%
|
Dec. 31, 2023 | USD 18.69 | -6.77% |
|
South Korea |
|
15 |
26.06%
|
Dec. 31, 2023 | USD 19.51 | -2.36% |
|
South Korea |
|
16 |
25.98%
|
Dec. 31, 2023 | USD 16.51 | 0.47% |
|
South Korea |
|
17 |
25.26%
|
Dec. 31, 2023 | USD 13.07 | -0.77% |
|
South Korea |
|
18 |
24.57%
|
Dec. 31, 2023 | USD 7.01 | -2.14% |
|
South Korea |
|
19 |
24.36%
|
Dec. 31, 2023 | USD 111.82 | -3.67% |
|
South Korea |
|
20 |
23.86%
|
Dec. 31, 2023 | USD 48.90 | -4.28% |
|
South Korea |
|
21 |
23.54%
|
Dec. 31, 2023 | USD 59.93 | -5.21% |
|
South Korea |
|
22 |
22.33%
|
Dec. 31, 2023 | USD 29.42 | -1.85% |
|
South Korea |
|
23 |
22.21%
|
Dec. 31, 2023 | USD 23.36 | -2.28% |
|
South Korea |
|
24 |
21.61%
|
Dec. 31, 2023 | USD 25.88 | -1.95% |
|
South Korea |
|
25 |
20.81%
|
Dec. 31, 2023 | USD 2.10 | -1.26% |
|
South Korea |
|
26 |
20.04%
|
Dec. 31, 2023 | USD 7.95 | -1.16% |
|
South Korea |
|
27 |
19.85%
|
Dec. 31, 2023 | USD 17.16 | -2.09% |
|
South Korea |
|
28 |
19.20%
|
Dec. 31, 2023 | USD 34.73 | -2.81% |
|
South Korea |
|
29 |
18.61%
|
Dec. 31, 2023 | USD 14.13 | -5.39% |
|
South Korea |
|
30 |
18.52%
|
Dec. 31, 2023 | USD 3.22 | 0.07% |
|
South Korea |
|
31 |
18.42%
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
32 |
18.31%
|
Dec. 31, 2023 | USD 15.77 | -2.26% |
|
South Korea |
|
33 |
18.21%
|
Dec. 31, 2023 | USD 32.69 | -0.97% |
|
South Korea |
|
34 |
18.00%
|
Dec. 31, 2023 | USD 7.90 | -1.67% |
|
South Korea |
|
35 |
17.72%
|
Dec. 31, 2023 | USD 88.12 | -2.63% |
|
South Korea |
|
36 |
17.64%
|
Dec. 31, 2023 | USD 35.28 | -1.85% |
|
South Korea |
|
37 |
17.63%
|
Dec. 31, 2023 | USD 7.67 | -7.46% |
|
South Korea |
|
38 |
17.32%
|
Dec. 31, 2023 | USD 25.91 | -1.31% |
|
South Korea |
|
39 |
17.31%
|
Dec. 31, 2023 | USD 51.82 | -2.58% |
|
South Korea |
|
40 |
17.23%
|
Dec. 31, 2023 | USD 56.39 | -4.53% |
|
South Korea |
|
41 |
16.85%
|
Dec. 31, 2023 | USD 7.96 | -1.24% |
|
South Korea |
|
42 |
16.59%
|
Dec. 31, 2023 | USD 26.42 | -2.41% |
|
South Korea |
|
43 |
16.55%
|
Dec. 31, 2023 | USD 32.48 | -0.87% |
|
South Korea |
|
44 |
16.35%
|
Dec. 31, 2023 | USD 2.94 | -0.95% |
|
South Korea |
|
45 |
15.89%
|
Dec. 31, 2023 | USD 60.06 | -1.60% |
|
South Korea |
|
46 |
14.86%
|
Dec. 31, 2023 | USD 9.65 | -0.29% |
|
South Korea |
|
47 |
14.79%
|
Dec. 31, 2023 | USD 77.77 | -3.69% |
|
South Korea |
|
48 |
14.63%
|
Dec. 31, 2023 | USD 15.70 | -4.70% |
|
South Korea |
|
49 |
14.53%
|
June 30, 2024 | USD 1.50 | -0.15% |
|
South Korea |
|
50 |
13.85%
|
Dec. 31, 2023 | USD 42.49 | -2.18% |
|
South Korea |
The Personal Care company in South Korea with the highest EBITDA Margin is LX Holdings Corp. (KSE: 383800.KS) at 69.11%.
The Personal Care company in South Korea with the lowest EBITDA Margin is CrystalGenomics, Inc. (KOSDAQ: 083790.KQ) at -877.23%.
The top 10 Personal Care companies in South Korea by EBITDA Margin are LX Holdings Corp., Solus Advanced Materials Co. Ltd., ORIENT BIO Inc., Samsung Biologics Co.,Ltd., PharmaResearch Co., Ltd., JETEMA, Co., Ltd., Lotte Non - Life Insurance Co., Ltd., KoMiCo Ltd., SG Global Co.,Ltd. and Boditech Med Inc..
The bottom 10 Personal Care companies in South Korea by EBITDA Margin are CrystalGenomics, Inc., Oscotec Inc., Humasis Co. Ltd., HLB Co., Ltd., Peptron, Inc., Sugentech Inc., PCL, Inc., Hyundai Bioscience Co., Ltd., Aprogen pharmaceuticals,Inc. and ICD Co., Ltd..